Development of researchers mobility policy guidelines for the region of Western Balkans
  
 

HomepageResearch Organisations Life Sciencelaboratory for Endocrinology and Metabolic Diseases, Institute of Nuclear Science Vinca
laboratory for Endocrinology and Metabolic Diseases, Institute of Nuclear Science Vinca
Insulin, IGF-1, Ang II, Estradiol, Diabetes, Hypertension, Signal transduction. 
laboratory for Endocrinology and Metabolic Diseases, Institute of Nuclear Science Vinca
DB reference 126
Type Research Institute
Research Area - Life Science - Health - Biotechnology
Research Projects 2000-2003: Pilot Project Program, Dean's Initiative inResearch Investment, "Vascular Interaction of Estradioland IGF-1 in Insulin Resistance", Principal Invest.: EsmaIsenovic, Ph.D. 2000-2003: NIH (1 R01 HL66119-01) "Ang II and IGF-1Interaction in Cardiovascular Tissue", Co-Investigator: 2001-2003: NOVARTIS: "Effect of Inhibition of the ReninAngiotensin System (RAS) on Insulin Sensitivity inVascular Smooth Muscle Cells (VSMC) and EndothelialCells (EC): Valsartan Effects on Insulin Mediated NitricOxide Production, Sodium Pump Activation and GlucoseTransport", Co-Investigator: Esma Isenovic, Ph.D. 2003-2003: NIH (1 R01) "Ang II Opposes Insulin MediatedVasorelaxation and Glucose Utilization: Role of ROS and RhoA", Co-Investigator: Esma Isenovic, Ph.D., 2002-2003: VA Merit Review "Vascular Protein Kinase B/Akt and Rho Signaling", Co-Investigator: Esma Isenovic, Ph.D 2004-present EU coperation Grant COST B17: " Obesityand Diabetes mellitus in the Elderly", Principal Invest.:Esma Isenovic, Ph.D. 2004-present European Commission Framework Programme: EqualProject (EC4): Multi-National External Quality Assay (EQA) Programmes in Clinical Molecular Diagnostics based on Performance and Interpretation of PCR assay including dissemination and training, supported by the European Community within the FP6 programme.Principal Invest.: Esma Isenovic, Ph.D. 2005: pending- Collaborative Grant with University of Ljubljana, School of Medicine, "Response to insulin on cellular level" Principal Invest.: Esma Isenovic, Ph.D. 
Address Mike Petrovica Alasa 12-14 P.O.Box 522 
City Belgrade
zip 11001
Country Serbia
Website www.vin.bg.ac.yu
Name PhD Esma Isenovic
Position Principal Scientist, Research Associate Professor
Phone + 381 11 243 81 34 
Fax   + 381 11 243 81 34
E-mail Isenovic@yahoo.com